![Biomolecules | Free Full-Text | The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies Biomolecules | Free Full-Text | The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies](https://www.mdpi.com/biomolecules/biomolecules-11-01558/article_deploy/html/images/biomolecules-11-01558-g001-550.jpg)
Biomolecules | Free Full-Text | The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
![Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines | Journal of Medicinal Chemistry Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm061066t/asset/images/medium/jm061066tf00003.gif)
Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines | Journal of Medicinal Chemistry
![Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines | Journal of Medicinal Chemistry Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm061066t/asset/images/medium/jm061066tn00001.gif)